With a crowd of social media platforms to master and so many digital marketing tools available, it’s not easy to determine which resources will work best for you and your company. As we discussed previously, social media is an important tool for life science companies. Maintaining an effective presence on leading social media platforms can…

Earlier this month, LaVoieHealthScience (LHS) announced the addition of Sharon Choe to our team. Sharon, who joined us from The Ruth Group in New York City, now serves as Senior Vice President, Investor Relations & Business Development with LHS. Sharon’s hiring marks a step forward for LHS into the NYC financial market. As an agency,…

The LaVoieHealthScience team was thrilled to kick off 2019 with another trip to San Francisco for the 37th Annual JP Morgan Healthcare Conference. Plenty of stories out of JPM19 trended online and made headlines. In this article, we highlight a few that caught our attention. Meeting Space at a Premium JPM19 boasted more than 10,000 attendees…

We’re in the midst of the fourth quarter, and it’s already time to begin planning for 2019. That means the annual confluence of industry conferences in San Francisco are just around the corner. Whether or not you are participating in the 37th Annual J.P. Morgan Healthcare Conference or the Biotech Showcase™, it’s time to review,…

Ever hear of Serial? How about Planet Money? Thanks to the growing popularity of podcasts, programs like these have become household names for millennials and older generations alike. Podcasts have changed the way many of us get our news, listen to stories, and learn about current trends.  They’re convenient, entertaining, informative and industry specific. We’ve…

How you tell your company’s story before, during and after an IPO can have a big impact on your valuation and market success  Preparing for an IPO signs you and your company up for months of hard strategizing, messaging and decision-making to effectively tap the public markets. With the complexities of changing market dynamics, mandated disclosures and Federal securities regulations, navigating the process is a challenge. And since the 2012 JOBS Act, allowing for confidential S-1 filing, many companies simply do…

In most industries – and especially when dealing with health and science innovation – it’s critical for communicators to reach an array of stakeholders: investors, business partners, consumers, regulatory agencies, the media and advocacy groups. Whether a company is privately-held or public, building branding and messaging that resonates across all stakeholder audiences is essential. On…

For pre-commercial life science companies, clinical trial data is king.  There may be other members of the court – regulatory decisions, business development and corporate updates – but trial data is clearly king.  Yet clinical trials take time, and there can be long stretches between data.  These data “deserts” can be especially trying for pre-commercial…

The Massachusetts biotech world was abuzz on June 14 as Governor Charlie Baker visited Bunker Hill Community College to sign into law a bill that will provide continued investment into the Commonwealth’s life sciences industry. The administration’s commitment to this initiative will help further secure Massachusetts as the world’s premier hub for innovation in medical…

We hear it all the time – my company wants to start a social media program, but we’re concerned we won’t have the content to maintain the program. To address this concern, LaVoieHealthScience recommends a two-tiered structure. First, develop three categories to “bucket” content, and use this framework to develop evergreen posts. Second, be prepared…